Cat. No. 2876
Chemical Name: (5aS,12S,14aS)-1,2,3,5a,6,11,12,14a
Biological ActivityChemosensitizing agent; selectively reverses BCRP-mediated multidrug resistance to mitoxantrone (Cat. No. 4250), doxorubicin (Cat. No. 2252) and topotecan (Cat. No. 4562) in transfected MCF-7 cells. Does not reverse resistance in P-gp- or MRP-positive cells. Analog (Ko 143, Cat. No. 3241) also available.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Rabindran et al (2000) Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res. 60 (47). PMID: 10646850.
Rabindran et al (1998) Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res. 58 5850. PMID: 9865745.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Fumitremorgin C from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Fumitremorgin C, supplier, mycotoxins, chemosensitisers, chemosensitizers, chemosensitizing, chemosensitising, BCRP, breast, cancer, resistance, proteins, reverses, multidrug, resistance, MDR, FumitremorginC, Tocris Bioscience, Multidrug Transporter Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent P-glycoprotein (P-gp) inhibitorCeefourin 1
Selective MRP4 inhibitor
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.